Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07389005

Exercise, Chronotype, and Prediabetes

The goal of this clinical trial is to find out whether exercising at the right time of day, based on a person's natural body clock, leads to greater health benefits in people living with prediabetes. The main question it aims to answer is whether doing a single session of exercise in the morning or in the evening affects how the body handles sugar differently in adults with prediabetes who have an extreme natural body clock. This will be done by comparing three conditions (no-exercise, morning exercise, and evening exercise) within the same participant. Each condition will be tested on a different day, with at least 14 days between the test days. During the no-exercise test days, participants will come to the study centre and will only be allowed to do sedentary activities (e.g. office work, reading, or screen time). During the morning exercise test days, participants will perform an exercise session at 9:00 am that involves short periods of very hard effort followed by short rest periods. Whereas for the evening exercise test days, the same type of exercise will be performed at 5:00 pm.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

19 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

About this study

Chronotype refers to an individual's circadian preferences for being active and fully functional at certain times of the day. Using validated questionnaires, individual's chronotype can be categorized to either a morning (lark), evening (owl), or intermediate (neutral) chronotypes. Individuals with morning chronotype wake up and go to bed early. Therefore, their calorie distribution as well as peak mental and physical performances predominantly occur earlier in the day. This is in contrast with individuals with evening chronotype that wake up and go to bed late, resulting in most of their calorie consumption happens later in the day. They are also more active and alert in the evening. Growing evidence has shown that late afternoon or evening exercise is better than morning exercise for blood glucose control in individuals with type 2 diabetes (T2D) or those at risk of T2D. In men with T2D, two weeks of high-intensity interval training (HIIT) reduced continuous glucose monitor (CGM)-based glucose concentration when performed in the afternoon than in the morning. This finding was further supported by a retrospective study involving men at risk for or T2D that found afternoon exercise led to superior peripheral insulin sensitivity, insulin-mediated suppression of adipose tissue lipolysis, and fasting plasma glucose. Interestingly, in a recently published crossover trial involving men and women, with and without T2D, no difference was observed in 24-hour glucose profile assessed using CGM across all cohorts (including gender and diabetes status) between morning and evening exercise. However, morning exercise increased post-exercise blood glucose levels during the two hours recovery period in both men and women with T2D, which was not observed following the evening exercise. It is important to note that all the above-mentioned studies are either excluding individuals with extreme chronotype or the chronotype of the participants was not clearly reported. This limitation raises an important research question: Do people living with extreme chronotype respond differently to timed exercise? Therefore, in this study, it is hypothesize that people living with prediabetes and extreme chronotype will gain superior metabolic benefits when the timing of exercise is aligned with their chronotype. To test this, a randomized controlled cross-over study is conducted in which participants are subjected to three conditions that are no-exercise, morning exercise, and evening exercise. The main outcome is insulin sensitivity determined by a 2-step hyperinsulinemic-euglycemic clamp.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Able to provide signed and dated written informed consent prior to any study specific procedures
  • Adult men and women aged between more than 18 and ≤ 75 years
  • Body mass index (BMI) of 25 - 35 kg/m2
  • Stable weight (no weight loss or gain > 3 kg in the past 3 months)
  • Pre-diabetes defined as an isolated impaired glucose tolerance or a combination of impaired glucose tolerance and impaired fasting glucose (values are based on the American Diabetes Association (ADA):
  • impaired glucose tolerance (plasma glucose 140 mg/dL to 199 mg/dL, 120 minutes after consumption of 75g of glucose)
  • impaired fasting glucose (fasting plasma glucose 100 mg/dL to 125 mg/dL)
  • Morning (Morningness-Eveningness Questionnaire [MEQ] score ≥ 59) or evening (MEQ score ≤ 41) chronotype

Exclusion criteria

  • Previously diagnosed with type 2 diabetes
  • Moderate to severe anemia (hemoglobin < 10 g/L)
  • Uncontrolled hypertension
  • Abnormal electrocardiogram (ECG) at rest judged by the study physician
  • Pregnancy or breastfeeding
  • HIV, hepatitis B, or C infection
  • Disorders of blood clotting or wound healing
  • Positive history of venous thrombosis (contraindication for clamp)
  • Hypersensitivity to local anesthetics (contraindication for fat/muscle biopsies)
  • Night shift work in the last 3 months
  • Travel across > 1 time zone in the last 3 months
  • Participation in another clinical trials that may possibly hamper the study results
  • Engagement in structured exercise activities > 2 hours a week
  • Any acute condition, exacerbation of chronic condition, or medical history that in the investigator's opinion would interfere with the study
  • Any contraindication for MRI scanning
  • Medication use known to hamper safety during the study procedures
  • Non-German speaking

Treatment and study plan

Timing of exercise

Behavioral

An acute exercise bout of cycling performed in the morning at 9 AM

Control

Behavioral

No exercise

Primary outcomes

  1. Insulin sensitivity

    Time frame: 12 to 24 hours post-exercise intervention

    Effect of timed exercise on insulin sensitivity assessed using insulin sensitivity index (reported as M-value: mg x kg-1 x min-1) during an hyperinsulinemic-euglycemic clamp

Secondary outcomes

  1. Skeletal muscle metabolites

    Time frame: 12 to 24 hours post-exercise intervention

    Effect of timed exercise on skeletal muscle mitochondrial respiration (pmol/mg/s) measured with high resolution respirometry

  2. Skeletal muscle clock genes

    Time frame: 12 to 24 hours post-exercise intervention

    Effect of timed exercise on quantified DNA measured with quantitative polymerase chain reaction (qPCR)

  3. Adipose tissue metabolites

    Time frame: 12 to 24 hours post-exercise intervention

    Effect of timed exercise on adipose tissue mitochondrial respiration (pmol/mg/s) measured with high resolution respirometry

  4. Adipose tissue clock genes

    Time frame: 12 to 24 hours post-exercise intervention

    Effect of timed exercise on quantified DNA measured with quantitative polymerase chain reaction (qPCR)

  5. Hepatic glycogen content assessed using 13C Magnetic Resonance Spectroscopy

    Time frame: Post-dinner on exercise day

    Effect of timed exercise on hepatic glycogen content, expressed in millimoles per liter (mmol/L) of liver tissue

  6. Serum glucose

    Time frame: 12 to 24 hours post-exercise intervention

    Effect of timed exercise on serum glucose levels (mg/dL) determined from venous blood draws

  7. Serum free fatty acids

    Time frame: 12 to 24 hours post-exercise intervention

    Effect of timed exercise on serum free fatty acid levels (mmol/L) determined from venous blood draws

  8. Serum triglycerides

    Time frame: 12 to 24 hours post-exercise intervention

    Effect of timed exercise on serum triglycerides (mg/dL) determined from venous blood draws

  9. Serum cholesterol

    Time frame: 12 to 24 hours post-exercise intervention

    Effect of timed exercise on serum cholesterol (mg/dL) determined from venous blood draws

  10. Serum insulin

    Time frame: 12 to 24 hours post-exercise intervention

    Effect of timed exercise on serum insulin levels (uIU/mL) determined from venous blood draws

  11. Resting energy expenditure assessed using indirect calorimetry

    Time frame: 12 to 24 hours post-exercise intervention

    Effect of timed exercise on resting energy expenditure, expressed in kilocalories per day (kcal/day)

  12. Objective sleep quantity and quality assessed using an actighrapy device

    Time frame: The nighttime of exercise intervention day

    Effect of timed exercise on sleep duration, efficiency, and fragmentation are measured objectively from the actighrapy device

Other outcomes

  1. Liver lipid content measured using ¹H/³¹P Magnetic Resonance Spectroscopy

    Time frame: Baseline assessment

    To assess the difference in liver lipid content in percentage (%) between morning versus evening chronotypes

  2. Skeletal muscle lipid content measured using ¹H/³¹P Magnetic Resonance Spectroscopy

    Time frame: Baseline assessment

    To assess the difference in skeletal muscle lipid content in percentage (%) between morning versus evening chronotypes

  3. Body composition expressed as fat mass (kg and %) and fat-free mass (kg) assessed using Bodpod and Bioelectrical Impedance

    Time frame: Baseline assessment

    To assess the difference in body composition between morning versus evening chronotypes

  4. Maximal aerobic capacity measured using spiroergometry

    Time frame: Baseline assessment

    To assess the difference in maximal aerobic capacity (VO₂max) between morning versus evening chronotypes

  5. Subjective sleep quality assessed using the Pittsburgh Sleep Quality Index (PSQI)

    Time frame: Baseline assessment

    To assess the difference in subjective sleep quality between morning versus evening chronotypes. Total score range of 1 to 21, higher scores indicating poorer sleep quality

  6. Level of sleepiness assessed using the Stanford Sleepiness Scale (SSS)

    Time frame: Baseline assessment

    To assess the difference in level of sleepiness between morning versus evening chronotypes. On a 7-point scale, 1 representing feeling alert and 7 indicating being almost in reverie

  7. Consumption of specific foods or food groups assessed using the DEGS1-Food Frequency Questionnaire (FFQ)

    Time frame: Baseline assessment

    To assess the difference in consumption frequency of specific foods or food groups (expressed as times per week) between morning versus evening chronotypes

  8. Hedonic hunger assessed using the Power of Food Scale questionnaire

    Time frame: Baseline assessment

    To assess the difference in hedonic hunger between morning versus evening. Mean score of 15 items rated on a 5-point Likert scale (range 1-5). Higher scores indicate greater psychological responsiveness to food cues

  9. Severity and type of food cravings assessed using the Control of Eating Questionnaire (CoEQ)

    Time frame: Baseline assessment

    To assess the difference in self-reported craving strength between morning versus evening chronotypes. A numeric rating scale ranges from 0 to 10. Higher scores indicate stronger food cravings

  10. Subjective physical activity levels determined using the International Physical Activity Questionnaire (IPAQ)

    Time frame: Baseline assessment

    To assess subjective physical activity levels (low, moderate, high expressed as MET-minutes/week) between morning versus evening chronotypes

  11. Cognitive performance assessed using the Sustained Attention to Response Test (SART)

    Time frame: Baseline assessment

    To assess the difference in cognitive performance between morning versus evening chronotypes. Performance is assessed using commission errors (incorrect responses to no-go stimuli), omission errors (missed responses to go stimuli), mean reaction time, and reaction time variability, with higher error rates and greater reaction time variability indicating poorer sustained attention and inhibitory control

  12. Cognitive performance assessed using the Brief Psychomotor Vigilance Test (PVT-B)

    Time frame: Baseline assessment

    To assess the difference in cognitive performance between morning versus evening chronotypes. Performance is assessed using mean reaction time, number of lapses (reaction times ≥500 ms), and fastest 10% reaction times, with slower reaction times and more lapses indicating reduced vigilant attention and alertness.

  13. Well-being assessed using the World Health Organization-Five Well-being Index (WHO-5)

    Time frame: Baseline assessment

    To assess the difference in well-being between morning versus evening chronotypes. Scores range from 0 to 25 with higher scores indicating better well-being and psychological health

  14. Mental health assessed using the Patient Health Questionnaire-9 (PHQ-9)

    Time frame: Baseline assessment

    To assess the difference in mental health between morning versus evening chronotypes. A 9-item self-report questionnaire assessing depressive symptoms over the past two weeks, scored from 0 to 27 with higher scores indicating greater severity of depressive symptoms

  15. Quality of life assessed using the 36-Item Short Form Survey Instrument (SF-36)

    Time frame: Baseline assessment

    To assess the difference in quality of life between morning versus evening chronotypes. A self-report questionnaire assessing health-related quality of life across eight domains-physical functioning, role limitations due to physical health, bodily pain, general health, vitality, social functioning, role limitations due to emotional problems, and mental health-with scores transformed to a 0-100 scale, where higher scores indicate better health and functioning

Study contacts

Contact information is provided by the study sponsor or research team.

Friedrich C. Jassil, PhD

CONTACT

[email protected]

+49 211 3382-685

Patrick Schrauwen, PhD

CONTACT

[email protected]

+49 211 3382-689

Sponsors and collaborators

Lead sponsor

German Diabetes Center

Other

Registry information

Official study title

Timed Exercise in Prediabetes With Extreme Chronotype

Important dates

Study start
2026
Primary completion
2028
Study completion
2028
First posted
Feb 5, 2026
Registry last updated
Feb 5, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.